kabutan

CellSource Co., Ltd.(4880) Summary

4880
TSE Prime
CellSource Co., Ltd.
435
JPY
-46
(-9.56%)
Dec 12, 3:30 pm JST
2.79
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
1.46
Yield
ー%
Margin Trading Ratio
27.13
Stock Price
Dec 12, 2025
Opening Dec 12, 9:09 am
450 JPY 2.89 USD
Previous Close Dec 11
481 JPY 3.08 USD
High Dec 12, 9:11 am
461 JPY 2.96 USD
Low Dec 12, 9:54 am
431 JPY 2.76 USD
Volume
563,500
Trading Value
0.25B JPY 1.60M USD
VWAP
441.37 JPY 2.83 USD
Minimum Trading Value
43,500 JPY 279 USD
Market Cap
8.62B JPY 0.06B USD
Number of Trades
704
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
208
1-Year High Dec 17, 2024
1,380
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 120,900 440,100 3.64
Nov 28, 2025 85,800 439,900 5.13
Nov 21, 2025 87,800 446,200 5.08
Nov 14, 2025 105,000 457,800 4.36
Nov 7, 2025 95,000 466,300 4.91
Company Profile
CellSource Co., Ltd. develops and sells regenerative medicine-related products and cosmetics, specializing in cell processing from fat and blood.
Sector
Pharmaceuticals
CellSource Co., Ltd. primarily focuses on regenerative medicine-related businesses, providing cell processing and storage services from blood and fat for medical institutions. The company operates facilities licensed for manufacturing specific cell products under the Act on the Safety of Regenerative Medicine, where they extract, culture, and cryopreserve adipose-derived stem cells. Additionally, CellSource offers consulting services for regulatory compliance and management support necessary for providing regenerative medicine, as well as sales of related medical equipment. Furthermore, the company manufactures and sells its own cosmetics brand "Signalift," which incorporates proprietary ingredients derived from adipose stem cell research. CellSource also supplies cosmetic raw materials and provides OEM manufacturing services.